SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence

This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes. The study includes both retrospective and prospective phases, with the collection of clinical, cognitive, and psychological data at various time points. Patients will undergo an early neuro-cognitive rehabilitation program using the RehaCom software, which will be conducted at home. The goal is to improve the quality of life and care for patients through a multidisciplinary and innovative approach.

NCT Number	NCT06878469
Lead Sponsor	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Collaborators: ASL 1 Avezzano Sulmona L'Aquila
Conditions	Brain Tumors
Enrollment	200 participants
Start Date	2025-01-27
Primary Completion	2025-07-01 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-02-19